Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites
Weixuan Chen, Yanli Pang
Metabolites (2021) Vol. 11, Iss. 12, pp. 869-869
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

The Influence of Sex Hormones in Liver Function and Disease
Alvile Kasarinaite, Matthew C. Sinton, Philippa T. K. Saunders, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1604-1604
Open Access | Times Cited: 49
When one size does not fit all: Reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments
Vittorio Unfer, Eleni Kandaraki, Lali Pkhaladze, et al.
Endocrine and Metabolic Science (2024) Vol. 14, pp. 100159-100159
Open Access | Times Cited: 18
The Influence of Metabolic Factors and Diet on Fertility
Klaudia Łakoma, Olha Kukharuk, Daniel Śliż
Nutrients (2023) Vol. 15, Iss. 5, pp. 1180-1180
Open Access | Times Cited: 41
Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
Mariam Farrag, Djedjiga Ait Eldjoudi, María González‐Rodriguez, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 38
Early identification of PCOS with commonly known diseases: Obesity, diabetes, high blood pressure and heart disease using machine learning techniques
Shivani Aggarwal, Kavita Pandey
Expert Systems with Applications (2023) Vol. 217, pp. 119532-119532
Closed Access | Times Cited: 31
Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies
Aleksandra Szczęsnowicz, Anna Szeliga, Olga Niwczyk, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5915-5915
Open Access | Times Cited: 24
Circulating levels of advanced glycation end products in females with polycystic ovary syndrome: a meta-analysis
Seyed Sobhan Bahreiny, Akram Ahangarpour, Mojtaba Aghaei
Reproductive and Developmental Medicine (2024) Vol. 8, Iss. 2, pp. 93-100
Open Access | Times Cited: 12
Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies
Achsha Babu, V. Devi Rajeswari, V. Ganesh, et al.
Reproductive Sciences (2024) Vol. 31, Iss. 6, pp. 1508-1520
Closed Access | Times Cited: 10
Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome
Ruihan Wang, Shanqin Qi, Q Wang, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update
Imadeldin Elfaki, Rashid Mir, Mohamed E. Elnageeb, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 83-83
Open Access | Times Cited: 1
Association of Polycystic Ovary Syndrome with Clinical, Physical, and Reproductive Factors: A Data-Driven Analysis
Ismat Ara Begum, A. S. M. Sanwar Hosen, Deepak Ghimire, et al.
Diagnostics (2025) Vol. 15, Iss. 6, pp. 711-711
Open Access | Times Cited: 1
Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
Ana Teresa Brinca, Ana Cristina Ramalhinho, Ângela Sousa, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1254-1254
Open Access | Times Cited: 37
Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome
Wenqian Li, Chang Liu, Qingmei Yang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 30
PCOS phenotype focus: phenotype D under the magnifying glass
Samuel H. Myers, Mario Montanino Oliva, Maurizio Nordio, et al.
Archives of Gynecology and Obstetrics (2024) Vol. 309, Iss. 6, pp. 2307-2313
Closed Access | Times Cited: 8
Bisphenol a downregulates GLUT4 expression by activating aryl hydrocarbon receptor to exacerbate polycystic ovary syndrome
Jing Shi, Kai-Lun Hu, Xiaoxue Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Roles of estrogen and its receptors in polycystic ovary syndrome
Yao Xu, Ziyi Zhang, Rongxiang Wang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota
Mingmin Zhang, Runan Hu, Yanjing Huang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients—The Debate Is Still Open
Jagoda Kruszewska, Hanna Laudy-Wiaderny, Michał Kunicki
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 4, pp. 2099-2099
Open Access | Times Cited: 23
Microbial composition across body sites in polycystic ovary syndrome: a systematic review and meta-analysis
Alberto Sola‐Leyva, Inmaculada Pérez‐Prieto, Nerea M. Molina, et al.
Reproductive BioMedicine Online (2023) Vol. 47, Iss. 1, pp. 129-150
Open Access | Times Cited: 14
The Metabolic Syndrome Puzzles; Possible Pathogenesis and Management
Basheer Abdullah Marzoog
Current Diabetes Reviews (2022) Vol. 19, Iss. 4
Closed Access | Times Cited: 20
Effects of intestinal flora on polycystic ovary syndrome
Jiayue Liu, Ying Liu, Xiaoliang Li
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers
Amedeo Lonardo
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 891-911
Closed Access | Times Cited: 12
The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results
Valeria Fedeli, Angela Catizone, Alessandro Querqui, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6296-6296
Open Access | Times Cited: 11
Associations of maternal per- and polyfluoroalkyl substance plasma concentrations during pregnancy with offspring polycystic ovary syndrome and related characteristics in Project Viva
Zifan Wang, Abby F. Fleisch, Sheryl L. Rifas‐Shiman, et al.
Environmental Research (2025), pp. 120786-120786
Closed Access
Metabolomics-Driven Insights into Biomarkers for Poor Ovarian Response: A Narrative Review
Anastasios Potiris, Sofoklis Stavros, Eleni Alyfanti, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 214-214
Open Access
Page 1 - Next Page

Scroll to top